Related Experiment Video
Updated: Apr 30, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Amino Acid-based Coacervates with Tunable Stimulus-Responsive Properties for Enhanced Acute Colitis Therapy
Fanchen Yu1,2, Suling Zhang3, Yang Xu1
1Beijing National Laboratory for Molecular Sciences (BNLMS), CAS Key Lab of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chinese Academy of Sciences, Beijing, P. R. China.
Researchers developed pH-stable amino acid coacervates for biomedicine. This molecular shielding strategy enables tunable coacervation across a wide pH range, enhancing drug delivery and cellular organization applications.
Area of Science:
- Biomaterials science
- Chemical biology
- Biomedical engineering
Background:
- Biomolecular condensates are vital for cellular organization and biomedicine.
- Limited pH stability of condensates restricts their use in diverse physiological settings.
- Developing pH-stable biomolecular systems is crucial for advanced biomedical applications.
Purpose of the Study:
- To engineer tunable coacervates from simple amino acids with broad pH stability.
- To investigate the thermoresponsive properties of these novel amino acid-based coacervates.
- To demonstrate the potential of pH-stable coacervates for in vivo drug delivery and therapy.
Main Methods:
- A molecular shielding strategy was employed to modify terminal ionizable groups of amino acids.
- Selective modification was used to create phase behavior independent of environmental pH.
- Coacervates were characterized for pH stability, thermoresponsive transitions (LCST/UCST), and in vivo performance.
Main Results:
- Tunable coacervation of simple amino acids was achieved over a wide pH range (1.0-13.0).
- The amino acid-based coacervates exhibited distinct thermoresponsive behaviors (LCST or UCST).
- N-terminal shielded phenylalanine coacervates demonstrated stability in gastric conditions and prolonged gastrointestinal drug retention.
Conclusions:
- Molecular shielding offers a method to create pH-independent amino acid coacervates.
- These programmable coacervates possess tunable thermoresponsive features for tailored applications.
- The study demonstrates successful in vivo oral drug delivery and therapy for acute colitis, highlighting potential for biomedical applications.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Modified-Release Drug Delivery Systems: Stimuli-Activated
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

